Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No additional AE; inadvertent administration of VARIVAX and PROQUAD concomitantly to a patient on 01OCT2025; inadvertent administration of VARIVAX and PROQUAD concomitantly to a patient on 01OCT2025; This spontaneous report was received from a nurse and refers to a 1-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 01-Oct-2025, the patient was inadvertently vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (strength, dose, frequency, lot #, and expiration date were not reported) and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (strength, dose, frequency, lot # and expiration date were not reported) for prophylaxis, and were diluted with sterile diluent, (strength, dose, frequency, indication, expiration date, and lot # were not reported) (Inappropriate schedule of product administration) (Overdose). No additional adverse event was reported. Lot # is being requested and will be submitted if received.
STERILE DILUENT